Mail

UK markets closed

FTSE 100
8,213.49
+41.34(+0.51%)
FTSE 250
20,164.54
+112.21(+0.56%)
AIM
771.53
+3.42(+0.45%)
GBP/EUR
1.1652
-0.0031(-0.26%)
GBP/USD
1.2546
+0.0013(+0.11%)
Bitcoin GBP
50,454.08
+445.16(+0.89%)

Best savings accounts that offer above inflation rates

Where to find a top-rated deal that works for you

Adicet Bio, Inc. (ACET)

NasdaqGM - NasdaqGM Real-time price. Currency in USD

Add to watchlist

1.4500

+0.0400

(+2.84%)

At close: 04:00PM EDT

1.4400

-0.01

(-0.69%)

After hours:

05:49PM EDT

Currency in USD

Valuation measures⁴

Market cap (intra-day)	119.15M
Enterprise value	-19.64M
Trailing P/E	N/A
Forward P/E	N/A
PEG ratio (5-yr expected)	N/A
Price/sales (ttm)	9.72
Price/book (mrq)	0.70
Enterprise value/revenue	2.14
Enterprise value/EBITDA	0.14

Trading information

Stock price history

Beta (5Y monthly)	1.62
52-week change ³	-78.83%
S&P500 52-week change ³	22.38%
52-week high ³	7.5000
52-week low ³	1.1000
50-day moving average ³	2.1598
200-day moving average ³	1.9816

Share statistics

Avg vol (3-month) ³	1.4M
Avg vol (10-day) ³	1.83M
Shares outstanding ⁵	82.17M
Implied shares outstanding ⁶	82.17M
Float ⁸	49.1M
% held by insiders ¹	1.42%
% held by institutions ¹	65.86%
Shares short (15 Apr 2024) ⁴	7.85M
Short ratio (15 Apr 2024) ⁴	7.35
Short % of float (15 Apr 2024) ⁴	11.14%
Short % of shares outstanding (15 Apr 2024) ⁴	9.56%
Shares short (prior month 15 Mar 2024) ⁴	5.81M

Dividends & splits

Forward annual dividend rate ⁴	N/A
Forward annual dividend yield ⁴	N/A
Trailing annual dividend rate ³	0.00
Trailing annual dividend yield ³	0.00%
5-year average dividend yield ⁴	N/A
Payout ratio ⁴	0.00%
Dividend date ³	16 Sept 2020
Ex-dividend date ⁴	N/A
Last split factor ²	1:7
Last split date ³	16 Sept 2020

Financial highlights

Fiscal year

Fiscal year ends	31 Dec 2023
Most-recent quarter (mrq)	31 Dec 2023

Profitability

Profit margin	0.00%
Operating margin (ttm)	0.00%

Management effectiveness

Return on assets (ttm)	-30.80%
Return on equity (ttm)	-61.69%

Income statement

Revenue (ttm)	N/A
Revenue per share (ttm)	N/A
Quarterly revenue growth (yoy)	N/A
Gross profit (ttm)	N/A
EBITDA	-126.48M
Net income avi to common (ttm)	-142.66M
Diluted EPS (ttm)	-3.3100
Quarterly earnings growth (yoy)	N/A

Balance sheet

Total cash (mrq)	159.71M
Total cash per share (mrq)	1.94
Total debt (mrq)	20.92M
Total debt/equity (mrq)	12.30%
Current ratio (mrq)	8.41
Book value per share (mrq)	3.93

Cash flow statement

Operating cash flow (ttm)	-93.72M
Levered free cash flow (ttm)	-61.28M